Despite numerous hepatitis C virus infection studies, its pathogenesis and medical treatment have not been fully explained. This comprehensive volume, written by experts in the field, covers the most recent advances in the study of HCV, moving from basic research to clinical applications. The first chapters of this volume analyze the full spectrum of immune responses to HCV. The volume also includes contributions that explain the state of the art in IFN-alpha treatment of HCV patients.
|Publisher:||Springer New York|
|Edition description:||Softcover reprint of hardcover 1st ed. 2008|
|Product dimensions:||6.10(w) x 9.25(h) x 0.24(d)|
Table of ContentsInnate Immunity in Type C Hepatitis.- Mechanisms of Interferon Action and Resistance in Chronic Hepatitis C Virus Infection: Lessons Learned from Cell Culture Studies.- Immunological Parameters Influencing Adaptive Immune Responses to the Hepatitis C Virus.- Immune Responses Against the Hepatitis C Virus and the Outcome of Therapy.- Other Microbial Components Associated with Hepatitis C Virus Infection: Their Effects on Interferon-?/Ribavirin Treatment.- Interferon-Induced Effector Proteins and Hepatitis C Virus Replication.- Treatment of Chronic Hepatitis C with Different Genotypes.- Interferon Treatment of Hepatitis C Virus Infection: From Basic Biology to Clinical Application.- Interferon-Based Therapy for Hepatitis C Virus Infections.- Treatment of Chronic Hepatitis C in “Difficult-to-Treat” Patients in the Clinical Setting.- Effects of Combined IFN-Alpha/Ribavirin Treatment in HCV Disease-Related Progression.- Pegylated Interferons: Clinical Applications in the Management of Hepatitis C Infection.